- The CTLA4 variants may interact with the IL23R-and NOD2-conferred risk in development of Crohn's disease2010 | First Faculty of Medicine
- The CTLA4 variants may interact with the IL23R-and NOD2-conferred risk in development of Crohn's disease2010 | Second Faculty of Medicine
- The CTLA4+49 A/G dimorphism is not associated with type 1 diabetes in Czech children2002 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Analysis of CTLA4 polymorphism in systemic lupus erytematodes patients from several European populationsPublication without faculty affiliation
- Genetic association of type 1 diabetes in an Azerbaijanian population: the HLA-DQ,-DRB1*04, the insulin gene, and CTLA42006 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Monogenic form of autoimmune diabetes as a part of dysregulation of immune system2018 | Second Faculty of Medicine
- Screening of monogenic autoimmune diabetes among children with type 1 diabetes and multiple autoimmune diseases: is it worth doing?2019 | Second Faculty of Medicine
- High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases2023 | First Faculty of Medicine, Third Faculty of Medicine
- Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy2018 | Second Faculty of Medicine
- LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells2021 | Second Faculty of Medicine
- Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme2017 | Faculty of Medicine in Pilsen
- Endocrine complications of modern cancer therapy2016 | Faculty of Medicine in Hradec Králové
- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects2018 | Second Faculty of Medicine
- Avelumab plus axitinib combination in treating metastatic renal cell carcinoma2022 | First Faculty of Medicine
- Therapeutic options for CTLA-4 Insufficiency2022 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer2019 | Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Progress in the treatment of cerebral metastases in advanced melanoma2018 | Publication without faculty affiliation
- Trial watch: Immune checkpoint blockers for cancer therapy2017 | Second Faculty of Medicine
- Immune-related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors2020 | Faculty of Medicine in Pilsen
- A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS2021 | Second Faculty of Medicine
- TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Ipilimumab for the treatment of metastatic prostate cancer2018 | Second Faculty of Medicine
- PD1+CD8+ Cells Are an Independent Prognostic Marker in Patients with Head and Neck Cancer2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Science
- Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB1*02-DQA1*05 and TNF -308A2006 | Second Faculty of Medicine, Faculty of Mathematics and Physics, Third Faculty of Medicine
- Gastrointestinal toxicity of systemic oncology immunotherapy2022 | First Faculty of Medicine, Central Library of Charles University
- CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID2019 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
